3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Recruiting
1
Sponsor Class
OTHER
3
INDUSTRY
2
Study Type
Observational
2
Sponsor
Cancer Type
Genitourinary
2
Thoracic
1
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Dermatologic
1
Breast
1
Conditions
Neoplasms
5
Uterine Cervical Neoplasms
3
Breast Neoplasms
3
Uterine Cervical Dysplasia
2
Urinary Bladder Neoplasms
2
Triple Negative Breast Neoplasms
2
Melanoma
2
Lung Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Neoplasms
1
Uterine Diseases
1
Uterine Cervical Diseases
1
Urogenital Neoplasms
1
Urogenital Diseases
1
Skin Neoplasms
1
Sarcoma, Endometrial Stromal
1
Precancerous Conditions
1
Neoplasms by Site
1
Neoplasm Metastasis
1
Liver Neoplasms
1
Leiomyosarcoma
1
Leiomyoma
1
Head and Neck Neoplasms
1
Genital Neoplasms, Female
1
Genital Diseases, Female
1
Genital Diseases
1
Female Urogenital Diseases and Pregnancy Complications
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Interventions
pembrolizumab
14
Nivolumab
13
Sunitinib
12
Axitinib
9
cabozantinib
8
belzutifan
8
Ipilimumab
7
Everolimus
5
atezolizumab
4
Sorafenib
4
temsirolimus
3
perifosine
3
motexafin gadolinium
3
Drug Therapy
3
spartalizumab
2
palbociclib
2
liposomal doxorubicin
2
lenvatinib
2
entinostat
2
ciforadenant
2
belinostat
2
avelumab
2
Paclitaxel
2
Immunotherapy
2
G250 monoclonal antibody
2
Fluorouracil
2
Docetaxel
2
Dexamethasone
2
Cetuximab
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
INDUSTRY
×
Kidney Neoplasms
×
Biopsy
×
Clear all
NCT07327489
2026-01-08
ELEPHAS-05
Elephas
Recruiting
2,000 enrolled
NCT06264479
2025-07-30
PEAR-TREE2
Ourotech, Inc.
Terminated
7 enrolled